Clinical Trials Browser

Phase 2 × Leukemia, Promyelocytic, Acute × Arsenic × Clear all

NCT06982274 2025-05-30

IC-APL2020

Phase 2 Recruiting

Other hematologic neoplasm

Leukemia, Promyelocytic, Acute